AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
373 hedge funds and large institutions have $7.06B invested in Amedisys in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 131 increasing their positions, 139 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
373
Holders Change
-14
Holders Change %
-3.62%
% of All Funds
6.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
45
Increased
131
Reduced
139
Closed
56
Calls
$20.3M
Puts
$46.3M
Net Calls
-$26M
Net Calls Change
-$19.9M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$85.4M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$48.9M |
| 3 |
Morgan Stanley
New York
|
+$25M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$24.2M |
| 5 |
JPMorgan Chase & Co
New York
|
+$23.8M |
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$46.6M |
| 2 |
BlackRock
New York
|
-$41.3M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$33.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$27.4M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$25.8M |
